Christopher Morrison
@ccmpharmd.bsky.social
father/husband; critical care pharmacist with specialty in neurocritical care and surgery/trauma critical care
Reposted by Christopher Morrison
Our inpt neuro pharm team is expanding at MGH! We are recruiting a pharmacist for a neurology/complex care position, where the pharmacist would split their time w/ the inpt stroke team and the complex care consult team. Reach out to me w ❓!
massgeneralbrigham.wd1.myworkdayjobs.com/en-US/MGBExt...
massgeneralbrigham.wd1.myworkdayjobs.com/en-US/MGBExt...
Clinical Pharmacist, Neurology and Complex Care Service
Site: The General Hospital Corporation At Mass General Brigham, we know it takes a surprising range of talented professionals to advance our mission—from doctors, nurses, business people and tech expe...
massgeneralbrigham.wd1.myworkdayjobs.com
February 4, 2025 at 2:07 PM
Our inpt neuro pharm team is expanding at MGH! We are recruiting a pharmacist for a neurology/complex care position, where the pharmacist would split their time w/ the inpt stroke team and the complex care consult team. Reach out to me w ❓!
massgeneralbrigham.wd1.myworkdayjobs.com/en-US/MGBExt...
massgeneralbrigham.wd1.myworkdayjobs.com/en-US/MGBExt...
Reposted by Christopher Morrison
The FDA gives Andexxa a thumbs down for full approval. It will be interesting to see what happens next in terms of formulary changes and future research.
www.fiercepharma.com/pharma/fda-r...
www.fiercepharma.com/pharma/fda-r...
FDA rejects J&J's subcutaneous Rybrevant filing and AZ's full approval bid for Andexxa
Johnson & Johnson has received coal in its stocking from the FDA as manufacturing issues have tripped up the company’s attempt to gain approval of its subcutaneous version of lung cancer drug R | The ...
www.fiercepharma.com
December 17, 2024 at 6:17 PM
The FDA gives Andexxa a thumbs down for full approval. It will be interesting to see what happens next in terms of formulary changes and future research.
www.fiercepharma.com/pharma/fda-r...
www.fiercepharma.com/pharma/fda-r...
Reposted by Christopher Morrison
November 15, 2024 at 10:42 PM